Agusta 2021: Hukumar Abinci da Magunguna ta amince da bishiyar asparaginase erwinia chrysanthemi (recombinant) -rywn) (Rylaze, Jazz Pharmaceuticals, Inc.) a matsayin wani ɓangare na tsarin magunguna daban-daban don maganin ciwon mara.
Agusta 2021: FDA ta amince da avapritinib (Ayvakit TM, Blueprint Medicines Corp.) ga marasa lafiya manya da mastocytosis na ci gaba (AdvSM), wanda ya haɗa da mastocytosis mai ƙarfi (ASM), mastocytosis na tsari tare da ..
Yuli 2021: Breyanzi (Lisocabtagene maraleucel; liso-cel), wani labari CD19-directed chimeric antigen receptor (CAR) T cell magani wanda Bristol Myers Squibb (BMS) ya haɓaka, Hukumar Abinci da Magunguna ta Amurka (US.
Saboda rarrabuwar cutar sankarar jini da rarrabewar hangen nesa suna da rikitarwa, babu wata hanyar da ta dace-da-duka-hanyar magani, kuma ya zama dole a haɗu da ƙididdigar hankali da kuma hangen nesa don tsara magani p ..
Eddle da Pearlie Saddler, kamar yadda matar sa Pearlie ke fata, "su more rayuwa ta yau da kullun" a garin su na South Carolina. Lokacin da suka huta, Saddlers sun ba da kansu kuma sun halarci hidimar a cocin. "Muna zuwa can sau da yawa, musamman Eddi ..
Wani sabon bincike da aka gudanar daga jami’ar McMaster da ke kasar Kanada ya bayyana cewa ya gano wani sabon tsarin dabarun magance cutar sankarar myeloid. Ta hanyar kara kuzarin samar da kwayoyin halitta masu dauke da kitse a cikin kasusuwan kasusuwa da kuma daidaita micronervir na kasusuwa ..
Acalabrutinib shine mai hanawa na ƙarni na biyu na tyrosine kinase (BTK) mai hanawa, sabon magani wanda zai iya inganta rayuwar cutar sankarar ƙwayar lymphocytic na yau da kullun (CLL) da kwayar cutar kwayar halitta ta jiki (MCL) .Masu binciken sun yi imanin cewa masu hana BTK sun haɗu ..
Wani binciken da aka gudanar a Asibitin yara na Los Angeles yana samar da mafi kyawon magani ga cutar sankarar bargo mai saurin haɗuwa da ake kira mixed phenotype m leukemia (MPAL) .Wannan binciken (kira na shekaru 20 na kimiyyar l ..
Dangane da sakamakon bin shekaru 5 na mahimmancin gwajin PACE da aka buga a cikin Journal of Hematology, panatinib (Ponatinib, Iclusig) ya ci gaba da dawwama a cikin majiyyatan da ke fama da cutar mai tsanani myeloi ..
Sabon binciken asibitin Cleveland ya nuna a karo na farko cewa ibrutinib da aka amince da shi na FDA (ibrutinib) na kwayar cutar lymphoma da leukemia na iya taimakawa wajen kula da cututtukan kwakwalwa da suka fi saurin mutuwa, kuma wata rana za a yi amfani da marasa lafiya da gliobla ..